A concise, selective synthesis of the polyketide spacer domain of a potent bryostatin analogue

Organic Letters

Volumn 5, Issue 3, 2003, Pages 277-279

  Wender, Paul A ^a   Mayweg, Alexander V W ^a   VanDeusen, Christopher L ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN; MACROLIDE; POLYKETIDE; BRYOSTATIN 1; LACTONE;

ARTICLE; CHEMICAL REACTION; DRUG POTENCY; DRUG SYNTHESIS; HYDROGENATION; REACTION ANALYSIS; REDUCTION; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

LACTONES; MACROLIDES; MOLECULAR STRUCTURE;

EID: 0013072917     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0272390     Document Type: Article

References (18)

1. (a) Mutter, R.; Wills, M. Bioorg. Med. Chem. 2000, 8, 1841-1860.
2. (b) Pettit, G. R. J. Nat. Prod. 1996, 59, 812-821.
3. (c) Hale, K. J.; Hummersone, M. G.; Manaviazar, S.; Frigerio, M. Nat. Prod. Rep. 2002, 19, 413-453.
4. For current information, see: http://clinicaltrials.gov
5. Wender, P. A.; Baryza, J. L.; Bennett, C. E.; Bi, F. C.; Brenner, S. E.; Clarke, M. O.; Horan, J. C.; Kan, C.; LaCote, E.; Lippa, B. S.; Nell, P. G.; Turner, T. M. J. Am. Chem. Soc. 2002, 124, 13648-13649.
6. (a) Wender, P. A.; Hinkle, K. W.; Koehler, M. F. T.; Lippa, B. Med. Res. Rev. 1999, 19, 388-407.
7. (b) Wender, P. A.; MartinCantalejo, Y.; Carpenter, A. J.; Chiu, A.; DeBrabander, J.; Harran, P. G.; Jimenez, J. M.; Koehler, M. F. T.; Lippa, B.; Morrison, J. A.; Muller, S. G.; Muller, S. N.; Park, C. M.; Shiozaki, M.; Siedenbiedel, C.; Skalitzky, D. J.; Tanaka, M.; Irie, K. Pure Appl. Chem. 1998, 70, 539-546.
8. (c) Unpublished results.
9. (a) Kitamura, M.; Ohkuma, T.; Inoue, S.; Sayo, N.; Kumabayashi, H.; Akutagawa, S.; Ohta, T.; Takaya, H.; Noyori, R. J. Am. Chem. Soc. 1988, 110, 629-631.
10. (b) For general reviews on 1,3-dicarbonyl reductions with ruthenium biarylbisphosphine catalysts see: (i) Noyori, R.; Kitamura, M.; Ohkuma, T. Asymmetric Hydrogenation. In Catalytic Asymmetric Synthesis, 2nd ed.: Ojima, I., Ed.; Wiley-VCH: New York, 2000. (ii) Ager, D. J.; Laneman, S. A. Tetrahedron: Asymmetry 1997, 8, 3327-3355.
11. (b) For general reviews on 1,3-dicarbonyl reductions with ruthenium biarylbisphosphine catalysts see: (i) Noyori, R.; Kitamura, M.; Ohkuma, T. Asymmetric Hydrogenation. In Catalytic Asymmetric Synthesis, 2nd ed.: Ojima, I., Ed.; Wiley-VCH: New York, 2000. (ii) Ager, D. J.; Laneman, S. A. Tetrahedron: Asymmetry 1997, 8, 3327-3355.
12. Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 95, 512-519.
13. 1H NMR.
14. (b) Kraus, G. A.; Molina, M. T.; Walling, J. A. J. Chem. Soc., Chem. Commun. 1986, 1568-1569.
15. (a) Noyori, R.; Ohkuma, T.; Kitamura, M.; Takaya, H.; Sayo, N.; Kumobayashi, H.; Akutagawa, S. J. Am. Chem. Soc. 1987, 109, 5856-5858.
16. (b) We believe this to be one of the more complex examples of a reduction of this type.
17. Zhao, M.; Li, J.; Mano, E.; Song, Z.; Tschaen, D. M.; Grabowski, E. J. J.; Reider, P. J. J. Org. Chem. 1999, 64, 2564-2566.
18. Coste, J.; Frérot, E.; Jouin, P. J. Org. Chem. 1994, 59, 2437-2446.